Skip to content
Company Analysis

Brainsway Ltd. BWAY

A comprehensive view of key metrics, scores, and financial health for Brainsway Ltd.

Overview of BrainsWay Ltd.

BWAY NGM
Healthcare Medical Devices Framework: Medical Devices & Diagnostics Small Cap
BrainsWay Ltd. (BWAY), is a Small Cap company, in the Medical Devices industry, last closed at $11.09, about 80.1% overvalued vs fair value, +42.3% 1Y return, placing in the top 10% of its sector.
Metrics P/E 52.8× Rev Growth 27.3% ROE 11.3% Gross Margin 75.4%
USD 11.09
-2.38%
(Delayed)
• Vol 90d: 50.7%
52-Week Range
Market Cap
$448.58M
Enterprise Value
$386.47M
Overall Score
View breakdown
Overall
Growth
Good
Profitability
Good
Health
Good
Efficiency
Fair
Valuation
Good
Growth
Good
Profitability
Good
Health
Good
Efficiency
Fair
Valuation
Good
Completeness: 82%
Confidence: 91%
Updated: Oct 31
Top Beats

Quick Facts

Website https://www.brainsway.com
HQ Jerusalem
Employees 120
Fiscal year Dec 31

Next Events

Earnings Nov 10 Call: Nov 11

Fair Value Snapshot

Bear Base Bull
$2
$2
$2
Current: $11.09 -80% vs base

Engine Room Money Flow™

Small Cap

Medical Devices & Diagnostics - Where revenue goes and how value is created

Flow Steps
Total Revenue
$52.2M
27.3%%
Gross Profit
$39.4M
28.8%%
Operating Income (GAAP)
$4.3M
210.8%%
EBITDA
$11.5M
69.8%%
Money Flow Bridge
Flow Direction: Money moves from left to right
Components: Breakdown shows composition of each stage
Industry-Specific: Medical Devices & Diagnostics

Quality & Reliability Indicators

Gross Margin
75.4%
Excellent

Gross Profit / Revenue — primary moat signal for MedTech. ≥65% indicates IP-protected consumables with strong pricing power.

Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium

Owner's Pocket - Capital Allocation

Where It Leaks

Cash Flow Health some concerns
Moderate efficiency issues detected. Review active leaks below for improvement areas.
1
Active Leaks
1/1
Improving
1
High Impact
0
Critical
Moat Analysis Medical Devices & Diagnostics

Competitive Advantage Assessment

Evaluating Brainsway Ltd.'s durable competitive advantages across 6 defense dimensions

Overall Moat Strength
80
/100
Strong
Scores based on quantitative metrics and qualitative factors
Full moat analysis

Key strengths

  • Elite Gross Margins Gross margin quality is top-tier vs peers (score 0.78). This signals strong consumable attach-rate economics.
  • Strong FCF Generation FCF margin quality is top-tier vs peers (score 0.99). High FCF conversion confirms strong earnings quality.

The dashed ring is the peer median. Defense scores are percentile ranks against peers, so 50 is roughly the typical company in this group.

Upgrade to unlock the signals and evidence behind each defense.

Premium access

Unlock full defense analysis

Get key signals, strengths, and risks for every moat dimension.

Upgrade to Premium Unlock all moat defenses and evidence.

Pricing Power & Consumable Moat

Strong
79
Premium

Signals, strengths and risks for Pricing Power & Consumable Moat

Premium

Signals, strengths and risks for R&D Pipeline & Capital Returns

Premium

Signals, strengths and risks for FCF Quality & Cash Conversion

Premium

Signals, strengths and risks for Commercial Execution

Premium

Signals, strengths and risks for Capital Structure & Resilience

Premium

Signals, strengths and risks for Growth Durability

Trade-Off Ledger™

Where management spends the performance budget - Growth, Profitability, or Safety

Healthcare: MedTech (Devices & Supplies) vs Industry Peers 92% Coverage
Trade-Off Triangle Visualization A ternary plot showing BWAY's balance between Growth (34.0%), Profitability (34.3%), and Safety (31.7%). Growth 34% Safety 32% Profitability 34%

Click axes to expand details. Marker shows current allocation.

3-Year Trend Analysis Locked
Upgrade to unlock the full 3-year trend analysis and deltas.

Growth

84th percentile vs peers
84
Key Signals
Rev Growth YoY 27.3% 84p EPS Growth YoY 1.00 90p Revenue CAGR 3Y 24.3% 78p Asset Growth YoY 19.7% 81p
Strengths
  • Growth performance in top 20% of peers (percentile: 84)
  • Rev Growth YoY in top 20% of peers (27.3%, 84th percentile)
  • EPS Growth YoY in top 20% of peers (1.00, 90th percentile)
  • FCF Margin in top 20% of peers (31.2%, 98th percentile)
Risks

No significant risks identified for this axis.

Profitability

85th percentile vs peers
85
Key Signals
Strengths
Risks
Premium
Unlock full Profitability drilldowns

See the signal-level drivers and insights behind this axis. Upgrade to reveal the full Trade-Off Ledger.

Upgrade Now

Safety

78th percentile vs peers
79
Key Signals
Strengths
Safety drilldowns are available to premium members.

Two Futures

Scenario-based fair value ranges for Brainsway Ltd..

Loading valuation model...
Unable to Compute Fair Value

This company cannot be valued using standard models.

What this means: The Scenario Theatre requires financial data (revenue, cash flow, shares outstanding) to calculate fair value estimates. This data may be unavailable for:

  • Recently listed companies (IPOs, SPACs)
  • Shell companies or holding companies
  • Companies that haven't filed recent financials
  • Foreign companies with limited data coverage
X.X%
X%XX%
X.X%
-XX%XX%
XX.X%
-XX%XX%
Adjust the sliders above to explore different valuation scenarios.
Unlock Premium
Reveal the full Scenario Theatre
See live sliders, narratives, and full Bear/Base/Bull outcomes.
Upgrade Now
Bear
-
- - -
- upside
-
Base
$2.21
- - -
-80.1% vs current
Snapshot base estimate
Bull
-
- - -
- upside
-
Fair Value Range Current: $-
$- $- $-
Actions & Info
Send Feedback
Please select a category.
0/1000